SYBLEU

SYBLEU EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of SYBLEU (SYBE) as of Nov 3, 2026 is -36.66. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -96.99 — a change of -62.20% (higher).

EV/EBIT

-36.66

YoY

-62.20%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of SYBLEU is 2023 -36.66 . EV/EBIT (Enterprise Value to EBIT) of SYBLEU was 2022 -96.99 . It decreases by -62.20% higher compared to the previous year.

The SYBLEU EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2020
-1,402.56 USD
Jan 1, 2021
-61.95 USD
Jan 1, 2022
-96.99 USD
Jan 1, 2023
-36.66 USD
The SYBLEU EV/EBIT history
YEAREV/EBITYoY
-36.66-62.20%
-96.99+56.56%
-61.95-95.58%
-1,402.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SYBLEU Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides SYBLEU's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates SYBLEU's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots SYBLEU's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if SYBLEU grows earnings faster than its peers.

SYBLEU Stock analysis

What does SYBLEU do? SYBLEU Inc develops regenerative medical applications focused on therapies for human and animal health, medical devices, and clinical diagnostics. The company generates revenue through the sale or licensing of its developed applications after completing Phase I or Phase II clinical trials, or by advancing them to Phase III trials. It also develops disposable medical devices and explores artificial intelligence and machine learning applications in clinical diagnostics. SYBLEU Inc targets the healthcare sector with its innovative medical solutions. The firm's primary products include therapies for human and animal health, medical devices, and clinical diagnostics. It also develops drugs for treating cancer in companion animals, leveraging artificial intelligence and machine learning in its diagnostic processes. SYBLEU Inc's business model relies on advancing its applications through clinical trials to either secure licensing deals or commercialize its products directly. SYBLEU Inc's target market segments are healthcare providers, veterinary clinics, and medical device manufacturers seeking innovative regenerative therapies and diagnostic tools. The company's focus on companion animal cancer treatments and AI-enhanced diagnostics positions it within specialized segments of the medical industry. Its development of disposable medical devices further expands its reach into the broader healthcare market. SYBLEU is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SYBLEU stock

EV/EBIT (Enterprise Value to EBIT) of SYBLEU is -36.66 in 2023.

EV/EBIT (Enterprise Value to EBIT) of SYBLEU changed from -96.99 to -36.66, representing a -62.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) SYBLEU since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s SYBLEU with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — SYBLEU

All Key Metrics — SYBLEU